Effects of once‐weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN‐6 trial

Autor:	Ahmed A. Kolkailah, Ildiko Lingvay, Idit Dobrecky‐Mery, Alona Aharonovich, Jens‐Peter David, Cecilie Holse, Søren Rasmussen, Darren K. McGuire
Rok vydání:	2022
Předmět:	Endocrinology Endocrinology Diabetes and Metabolism Internal Medicine
Zdroj:	Diabetes, Obesity and Metabolism. 25:1117-1120
ISSN:	1463-1326 1462-8902
DOI:	10.1111/dom.14941
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e75fffa7ea4fd1db9e546e3bce862c https://doi.org/10.1111/dom.14941 Zobrazit plný text záznamu Plný text